How many employees work at Novartis Gene Therapies?
Novartis Gene Therapies, Inc. has approximately 44 total employees worldwide as of March 2026, according to Revelio Labs workforce intelligence data. Novartis Gene Therapies’s total headcount has declined 55.7% from 98 employees in 2023 to 44 in 2026.
Is Novartis Gene Therapies hiring right now?
No, Novartis Gene Therapies is not actively hiring. Novartis Gene Therapies had 0 active job postings in 2026, a 0.0% no change from 2025 — see job openings & hiring trends.
About Novartis Gene Therapies’s Workforce
Novartis Gene Therapies, Inc. is a Pharmaceuticals company that employs 44 people worldwide as of March 2026. It is the 10th-largest by headcount among its peers. Founded in 2010, the company is headquartered in Bannockburn, Illinois.
Novartis Gene Therapies's workforce has declined 55.7% from 2023 to 2026, down 8.4% year over year in 2026. It fell to a low of 43 in 2025 Q4 before recovering. Its workforce is concentrated most in North America (92.1%), followed by Western Europe (2.4%) and Northern Europe (2.2%).
Novartis Gene Therapies's functional groups are Finance and Operations (51.4%), Sales and Marketing (25.8%), and Engineering (22.7%), with Engineering growing fastest (up 13.7%). The average salary is $151,668, highest in North America at a median of $138,000, down 1.1% year over year in 2026.
Novartis Gene Therapies's hiring activity held steady in 2026. Overall employee sentiment is neutral but improving.
Sourced from Revelio Labs workforce data.
- Headquarters
- Bannockburn, Illinois
- Founded
- 2010
- Industry
- Pharmaceuticals
- Employees
- 44
- YoY
- -8.4% (-3)
As of March 2026
Novartis Gene Therapies workforce metrics
Unlock hiring rate, attrition rate, and 12 additional workforce metrics for Novartis Gene Therapies. Compare to peers, export the dataset, and access the full quarterly history.
Unlock MetricsNovartis Gene Therapies Annual Employee Count (2023-2026)
- Novartis Gene Therapies had 44 employees in 2026, a 8.4% decline (-3) from 2025.
- Novartis Gene Therapies had 43 employees in 2025, a 17.8% decline (-12) from 2024.
- Novartis Gene Therapies had 55 employees in 2024, a 31.7% decline (-23) from 2023.
- Novartis Gene Therapies had 78 employees in 2023, a 30.6% decline (-44) from 2022.
Novartis Gene Therapies's total workforce has grown from 43 employees in 2025 to 44 in 2026. Novartis Gene Therapies's headcount peaked at 98 in 2023 before declining in 2025 and recovering through 2026.
Novartis Gene Therapies, Inc. quarterly employee count
| Year | Qtr | Employees | YoY Change | YoY % |
|---|---|---|---|---|
| 2026 | Q1 | 44 | -3 | -8.4% |
| 2025 | Q4 | 43 | -12 | -17.8% |
| 2025 | Q3 | 45 | -12 | -18.7% |
| 2025 | Q2 | 46 | -18 | -27.5% |
| 2025 | Q1 | 47 | -19 | -33.2% |
| 2024 | Q4 | 55 | -23 | -31.7% |
| 2024 | Q3 | 57 | -25 | -33.6% |
| 2024 | Q2 | 64 | -34 | -34.0% |
| 2024 | Q1 | 66 | -44 | -35.6% |
| 2023 | Q4 | 78 | -44 | -30.6% |
| 2023 | Q3 | 82 | -48 | -29.3% |
| 2023 | Q2 | 98 | -45 | -23.0% |
See Novartis Gene Therapies's complete headcount history, including quarterly breakdowns.
Get the DataNovartis Gene Therapies Employee Count by Region (2026)
North America accounts for the largest share of Novartis Gene Therapies's global workforce with approximately 92% of total employees, followed by Western Europe and Northern Europe.
Novartis Gene Therapies employees by region
| Region | Employees | % of Total |
|---|---|---|
| North America | 40 | 92.1% |
| Western Europe | 1 | 2.4% |
| Northern Europe | 1 | 2.2% |
| Sub-Saharan Africa | 1 | 1.9% |
| Eastern Europe | 1 | 1.4% |
Drill into city-level data, hiring trends by region, and historic geographic shifts.
Unlock Geographic DataNovartis Gene Therapies Employee Count by Department (2026)
Novartis Gene Therapies's employee groups are Finance and Operations (51.4%), Sales and Marketing (25.8%), and Engineering (22.7%).
Novartis Gene Therapies employees by department
| Department | Employees | % of Total |
|---|---|---|
| Finance and Operations | 22 | 51.4% |
| Sales and Marketing | 11 | 25.8% |
| Engineering | 10 | 22.7% |
Compare Novartis Gene Therapies's department mix to industry peers.
See Full DataNovartis Gene Therapies Employee Salary by Region (2026)
Novartis Gene Therapies's average employee salary is $151,668 globally. Employees in North America receive the highest compensation.
Novartis Gene Therapies median employee salary by region (USD)
| Region | Median Salary |
|---|---|
| North America | $138,000 |
Unlock salary by role, level, and city — and compare to Novartis Gene Therapies's industry peers.
Unlock Salary DataNovartis Gene Therapies Job Openings and Hiring Trends (2023-2026)
- Novartis Gene Therapies had 0 active job postings in 2026, a 0% no change from 2025.
- Novartis Gene Therapies had 0 active job postings in 2025, a 0% no change from 2024.
- Novartis Gene Therapies had 0 active job postings in 2024, a 200.0% decline (-1) from 2023.
- Novartis Gene Therapies had 1 active job postings in 2023, a 133.3% decline from 2022.
- Hiring velocity in 2026: 0 new roles/month, up from 0 in 2025 and 0 in 2024.
Novartis Gene Therapies's hiring activity held steady in 2026.
Track new postings per month, role-level demand, and hiring velocity vs. peers.
Unlock Hiring DataNovartis Gene Therapies Employee Sentiment (2026)
Revelio Labs tracks employee sentiment across Novartis Gene Therapies's workforce based on public professional data. Overall sentiment is neutral and has improved year over year in 2026.
Overall
Unlock the full sentiment breakdown by department, tenure, and trend over time.
Unlock SentimentSimilar Companies
Similar Pharmaceuticals Companies by Employee Count
Frequently Asked Questions About Novartis Gene Therapies
- How fast is Novartis Gene Therapies growing?
- In 2026, Novartis Gene Therapies's headcount shrank 8.4% to 44 employees, down from 47 in 2025.
- See the full headcount history
- Where are Novartis Gene Therapies employees located?
- Most Novartis Gene Therapies employees are based in North America (92.1% of headcount), followed by Western Europe and Northern Europe.
- Explore where the workforce is based
- What is the average salary at Novartis Gene Therapies?
- The average employee salary at Novartis Gene Therapies is approximately $151.7k per year.
- Analyze the salary distribution
- How many new job postings does Novartis Gene Therapies open per year?
- In Q1 2026, Novartis Gene Therapies opened 0 new job postings. In 2025, Novartis Gene Therapies opened 0 new job postings — about 0 per month.
- Track hiring trends by role
- When was Novartis Gene Therapies founded and where is it headquartered?
- Novartis Gene Therapies was founded in 2010 and is headquartered in Bannockburn, Illinois.
- Compare Novartis Gene Therapies to industry peers
Speak with a workforce expert about Novartis Gene Therapies.
Book a DemoSee something that doesn't look right? Reach out and our team will review it.